Litcius/Paper detail

Lecanemab for Alzheimer's disease: tempering hype and hope

The Lancet

2022The Lancet99 citationsDOI

Topics & Concepts

MedicineClinical trialDiseaseDementiaInternal medicineAlzheimer's disease research and treatmentsCholinesterase and Neurodegenerative DiseasesNeuroinflammation and Neurodegeneration Mechanisms